Joseph Allen

Joseph Allen

Joseph Allen is a Featured Contributor on IPWatchdog.com, and a 30-year veteran of national efforts to foster public/private sector commercialization partnerships, and author of numerous articles on technology management for national publications.

Joe served as a Professional Staff Member on the U.S. Senate Judiciary Committee with former Senator Birch Bayh (D-IN), and was instrumental in working behind the scenes to ensure passage of the historic Bayh-Dole Act. He is our resident Bayh-Dole expert, and will write frequently about Bayh-Dole and issues surrounding the commercialization of university research.

In 2008, Joe founded Allen & Associates, through which he offers consulting services assisting clients in technology transfer issues, including developing effective communication strategies with national policy makers.


Posts by Joseph Allen


Don’t Ignore the Flashing Caution Lights in the Drug Pricing Debate

Trying to rationally address hot button issues in an election year is always a dangerous proposition. That's particularly true as we approach what promises to be one …
By Joseph Allen
2 years ago 1

The ‘Dragon’ Targets U.S. Biopharma Lead

Perhaps the report on China's strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because …
By Joseph Allen
2 years ago 2

Laws, Leadership and Luck: Why Bayh-Dole Worked But the Federal Circuit Went Off-Course

I recently visited Egypt as part of a team led by the Departments of State and Agriculture, supported by the good folks at the AUTM Foundation. Egypt, …
By Joseph Allen
2 years ago 5

Bayh-Dole Rocks While the Critics Play the Same False Note

A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. …
By Joseph Allen
2 years ago 0

House Drug Pricing Hearing Goes Off Script

Most Congressional hearings are morality plays designed to reach a predetermined outcome. It wasn't hard to predict how the second hearing on drug pricing by the House …
By Joseph Allen
2 years ago 5

The Washington Post Misses the Mark on March-In Rights

The National Institute of Standards and Technology recently indicated in its "Return on Investment Initiative draft green paper" that it would issue regulations effectively ending attempts to …
By Joseph Allen
2 years ago 2

In Memory: Farewell to Senator Birch Bayh

On Wednesday, March 14, we lost Senator Birch Bayh.  We knew for several months that this day wasn't far off, as his health rapidly declined.  I wanted to …
By Joseph Allen
2 years ago 5

New Study Shows Bayh-Dole is Working as Intended—and the Critics Howl

Just as the drug pricing debate on Capitol Hill is heating up, an important new study, "The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation …
By Joseph Allen
2 years ago 1

If We Don’t Develop Best Practices Ourselves, the Government Will

I recently delivered a keynote address at a special session of the AUTM Annual Meeting, where the Advanced Medical Technology Association (AdvaMed) released its new University Technology …
By Joseph Allen
2 years ago 4

Patents in the Crosshairs During House Drug Pricing Debate

The opening salvo in what promises to be one of the hottest debates in the new Congress was fired January 29 during a day-long hearing in the House …
By Joseph Allen
2 years ago 28

Happy Birthday, Senator Birch Bayh

Hopefully, you've been fortunate enough—at least once in your life—to work for someone you really admired. That happened to me as a Senate Judiciary Committee …
By Joseph Allen
2 years ago 3

Fine Tuning the Trump Administration’s ROI Initiative

The Trump Administration's Return on Investment (ROI) Initiative, which is geared toward increasing the American taxpayer's benefits from federally-supported R&D, is potentially a big step forward. …
By Joseph Allen
2 years ago 0

The Administration’s Draft ROI Report: A Promising Roadmap for Accelerating Tech Transfer

After months of anticipation, the just released draft paper Return on Investment Initiative to Advance the President's Management Agenda: Unleashing American Innovation signals that the Administration is …
By Joseph Allen
3 years ago 4

Universities: Fallen Angels or Stewards of Bayh-Dole?

University discoveries are recognized as critical national assets because Bayh-Dole gave academic institutions the ability to own and manage inventions made with federal funding. The law helped …
By Joseph Allen
3 years ago 4

A Shot at Patents Misses the Mark and New Study Reinforces Need to Examine Federal Tech Transfer

Academic institutions and federal labs receive approximately the same amount of  R&D funding from the government, although universities have more money overall because of contributions from …
By Joseph Allen
3 years ago 2